| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.54B | $1.95B | $2.54B |
| YoY Revenue Growth % | -20.8% | -23.3% | — |
| Gross Profit | — | $265.1M | — |
| Gross Margin % | — | 13.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $307.5M | -$356.1M | $311.9M |
| Operating Margin % | 19.9% | -18.3% | 12.3% |
| Net Income (GAAP) | $211.5M | -$284.1M | $231.3M |
| EBITDA (Normalized) | $327.3M | -$298.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $11.7M | $117.3M | $319.6M |
| Capital Expenditures (CapEx) | $24.7M | $72.2M | — |
| Free Cash Flow (FCF) | -$13.0M | $45.1M | $319.6M |
| FCF Margin % | -0.8% | 2.3% | 12.6% |
| Return on Invested Capital (ROIC %) | 31.2% | -45.0% | — |
| Cash & Short-Term Equivalents | $31.9M | $115.5M | — |
| Total Debt (Short + Long Term) | $442.9M | $397.1M | — |
| Total Stockholders' Equity | $367.4M | $188.8M | — |